Recent studies in pancreatic cancer cell lines found that metformin may inhibit growth independently of AMPK through upregulation of miR-26a [45], while metformin’s effects on pancreatic cancer stem cells may be mediated through reexpression of specific miRNAs [18]. This evidence concerns the gene PRKAA1 and pancreatic neoplasm.